Warning: Undefined array key "mm" in /www/wwwroot/www.ai-bt.com/si.php on line 10 Deprecated: trim(): Passing null to parameter #1 ($string) of type string is deprecated in /www/wwwroot/www.ai-bt.com/si.php on line 10 Allocation of patients to treatment groups in a controlled clinical study.

Literature DB >> 350254

Allocation of patients to treatment groups in a controlled clinical study.

Abstract

In a controlled clinical study ("clinical trial") to compare 2 or more treatments for a disease, an objective method of allocating patients to treatment groups is needed. Various existing methods of allocation are described, including those which take account of patients' pre-treatment characteristics.

Entities: Species

Mesh：

Year: 1978 PMID： 350254 PMCID： PMC2009630 DOI： 10.1038/bjc.1978.124

Source DB: PubMed Journal: Br J Cancer ISSN： 0007-0920 Impact factor: 7.640

6 in total

1. On the use of Pocock and Simon's method for balancing treatment numbers over prognostic factors in the controlled clinical trial.

Authors: L S Freedman; S J White
Journal: Biometrics Date: 1976-09 Impact factor: 2.571

2. Minimization: a new method of assigning patients to treatment and control groups.

Authors: D R Taves
Journal: Clin Pharmacol Ther Date: 1974-05 Impact factor: 6.875

Review 3. Statistical methods for the identification and use of prognostic factors.

Authors: P Armitage; E A Gehan
Journal: Int J Cancer Date: 1974-01-15 Impact factor: 7.396

4. Sequential treatment assignment with balancing for prognostic factors in the controlled clinical trial.

Authors: S J Pocock; R Simon
Journal: Biometrics Date: 1975-03 Impact factor: 2.571

5. Design and analysis of randomized clinical trials requiring prolonged observation of each patient. I. Introduction and design.

Authors: R Peto; M C Pike; P Armitage; N E Breslow; D R Cox; S V Howard; N Mantel; K McPherson; J Peto; P G Smith
Journal: Br J Cancer Date: 1976-12 Impact factor: 7.640

6. Design and analysis of randomized clinical trials requiring prolonged observation of each patient. II. analysis and examples.

Authors: R Peto; M C Pike; P Armitage; N E Breslow; D R Cox; S V Howard; N Mantel; K McPherson; J Peto; P G Smith
Journal: Br J Cancer Date: 1977-01 Impact factor: 7.640

6 in total

45 in total

1. Neoadjuvant plus adjuvant bevacizumab in early breast cancer (NSABP B-40 [NRG Oncology]): secondary outcomes of a phase 3, randomised controlled trial.

Authors: Harry D Bear; Gong Tang; Priya Rastogi; Charles E Geyer; Qing Liu; André Robidoux; Luis Baez-Diaz; Adam M Brufsky; Rita S Mehta; Louis Fehrenbacher; James A Young; Francis M Senecal; Rakesh Gaur; Richard G Margolese; Paul T Adams; Howard M Gross; Joseph P Costantino; Soonmyung Paik; Sandra M Swain; Eleftherios P Mamounas; Norman Wolmark
Journal: Lancet Oncol Date: 2015-08-10 Impact factor: 41.316

2. Use of letrozole after aromatase inhibitor-based therapy in postmenopausal breast cancer (NRG Oncology/NSABP B-42): a randomised, double-blind, placebo-controlled, phase 3 trial.

Authors: Eleftherios P Mamounas; Hanna Bandos; Barry C Lembersky; Jong-Hyeon Jeong; Charles E Geyer; Priya Rastogi; Louis Fehrenbacher; Mark L Graham; Stephen K Chia; Adam M Brufsky; Janice M Walshe; Gamini S Soori; Shaker R Dakhil; Thomas E Seay; James L Wade; Edward C McCarron; Soonmyung Paik; Sandra M Swain; D Lawrence Wickerham; Norman Wolmark
Journal: Lancet Oncol Date: 2018-11-30 Impact factor: 41.316

3. Light treatment for neuropsychiatric behaviors in Alzheimer's disease.

Authors: Glenna A Dowling; Carla L Graf; Erin M Hubbard; Jay S Luxenberg
Journal: West J Nurs Res Date: 2007-06-27 Impact factor: 1.967

4. Progesterone to prevent miscarriage in women with early pregnancy bleeding: the PRISM RCT.

Authors: Arri Coomarasamy; Hoda M Harb; Adam J Devall; Versha Cheed; Tracy E Roberts; Ilias Goranitis; Chidubem B Ogwulu; Helen M Williams; Ioannis D Gallos; Abey Eapen; Jane P Daniels; Amna Ahmed; Ruth Bender-Atik; Kalsang Bhatia; Cecilia Bottomley; Jane Brewin; Meenakshi Choudhary; Fiona Crosfill; Shilpa Deb; W Colin Duncan; Andrew Ewer; Kim Hinshaw; Thomas Holland; Feras Izzat; Jemma Johns; Mary-Ann Lumsden; Padma Manda; Jane E Norman; Natalie Nunes; Caroline E Overton; Kathiuska Kriedt; Siobhan Quenby; Sandhya Rao; Jackie Ross; Anupama Shahid; Martyn Underwood; Nirmala Vaithilingham; Linda Watkins; Catherine Wykes; Andrew W Horne; Davor Jurkovic; Lee J Middleton
Journal: Health Technol Assess Date: 2020-06 Impact factor: 4.014

5. The Resources for Enhancing Alzheimer's Caregiver Health (REACH): project design and baseline characteristics.

Authors: Stephen R Wisniewski; Steven H Belle; David W Coon; Susan M Marcus; Marcia G Ory; Louis D Burgio; Robert Burns; Richard Schulz
Journal: Psychol Aging Date: 2003-09

6. Psychological, behavioral, and immune changes after a psychological intervention: a clinical trial.

Authors: Barbara L Andersen; William B Farrar; Deanna M Golden-Kreutz; Ronald Glaser; Charles F Emery; Timothy R Crespin; Charles L Shapiro; William E Carson
Journal: J Clin Oncol Date: 2004-09-01 Impact factor: 44.544

7. Preoperative multimodality therapy improves disease-free survival in patients with carcinoma of the rectum: NSABP R-03.

Authors: Mark S Roh; Linda H Colangelo; Michael J O'Connell; Greg Yothers; Melvin Deutsch; Carmen J Allegra; Morton S Kahlenberg; Luis Baez-Diaz; Carol S Ursiny; Nicholas J Petrelli; Norman Wolmark
Journal: J Clin Oncol Date: 2009-09-21 Impact factor: 44.544